These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18092129)

  • 21. Relative expression and correlation of tumor necrosis factor-α, interferon-γ, and interleukin-17 in the rheumatoid synovium.
    Nakajima A; Aoki Y; Sonobe M; Watanabe F; Takahashi H; Saito M; Nakagawa K
    Clin Rheumatol; 2016 Jul; 35(7):1691-7. PubMed ID: 27038187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TNF blockade requires 1,25(OH)2D3 to control human Th17-mediated synovial inflammation.
    van Hamburg JP; Asmawidjaja PS; Davelaar N; Mus AM; Cornelissen F; van Leeuwen JP; Hazes JM; Dolhain RJ; Bakx PA; Colin EM; Lubberts E
    Ann Rheum Dis; 2012 Apr; 71(4):606-12. PubMed ID: 22219138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preferential induction of prodestructive matrix metalloproteinase-1 and proinflammatory interleukin 6 and prostaglandin E2 in rheumatoid arthritis synovial fibroblasts via tumor necrosis factor receptor-55.
    Alsalameh S; Amin RJ; Kunisch E; Jasin HE; Kinne RW
    J Rheumatol; 2003 Aug; 30(8):1680-90. PubMed ID: 12913922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report.
    Catrina AI; Trollmo C; af Klint E; Engstrom M; Lampa J; Hermansson Y; Klareskog L; Ulfgren AK
    Arthritis Rheum; 2005 Jan; 52(1):61-72. PubMed ID: 15641091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M; Zwicker M; Villiger PM
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medication effectiveness with the use of tumor necrosis factor inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis.
    Oladapo A; Barner JC; Lawson KA; Novak S; Rascati KL; Richards KM; Harrison DJ
    J Manag Care Spec Pharm; 2014 Jul; 20(7):657-67. PubMed ID: 24967519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of infliximab therapy on gene expression levels of tumor necrosis factor alpha, tristetraprolin, T cell intracellular antigen 1, and Hu antigen R in patients with rheumatoid arthritis.
    Sugihara M; Tsutsumi A; Suzuki E; Wakamatsu E; Suzuki T; Ogishima H; Hayashi T; Chino Y; Ishii W; Mamura M; Goto D; Matsumoto I; Ito S; Sumida T
    Arthritis Rheum; 2007 Jul; 56(7):2160-9. PubMed ID: 17599736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term treatment with etanercept significantly reduces the number of proinflammatory cytokine-secreting peripheral blood mononuclear cells in patients with rheumatoid arthritis.
    Schotte H; Schlüter B; Willeke P; Mickholz E; Schorat MA; Domschke W; Gaubitz M
    Rheumatology (Oxford); 2004 Aug; 43(8):960-4. PubMed ID: 15026584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-1β measurement in stimulated whole blood cultures is useful to predict response to anti-TNF therapies in rheumatoid arthritis.
    Kayakabe K; Kuroiwa T; Sakurai N; Ikeuchi H; Kadiombo AT; Sakairi T; Kaneko Y; Maeshima A; Hiromura K; Nojima Y
    Rheumatology (Oxford); 2012 Sep; 51(9):1639-43. PubMed ID: 22596214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
    Woolley DE; Tetlow LC
    Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Etanercept treatment reduces the serum levels of interleukin-15 and interferon-gamma inducible protein-10 in patients with rheumatoid arthritis.
    Ichikawa T; Kageyama Y; Kobayashi H; Kato N; Tsujimura K; Koide Y
    Rheumatol Int; 2010 Apr; 30(6):725-30. PubMed ID: 20062995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Norepinephrine from synovial tyrosine hydroxylase positive cells is a strong indicator of synovial inflammation in rheumatoid arthritis.
    Miller LE; Grifka J; Schölmerich J; Straub RH
    J Rheumatol; 2002 Mar; 29(3):427-35. PubMed ID: 11908553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-21 induces T-cell activation and proinflammatory cytokine secretion in rheumatoid arthritis.
    Li J; Shen W; Kong K; Liu Z
    Scand J Immunol; 2006 Nov; 64(5):515-22. PubMed ID: 17032244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: effects of tumor necrosis factor-alpha blockade.
    Ingegnoli F; Fantini F; Favalli EG; Soldi A; Griffini S; Galbiati V; Meroni PL; Cugno M
    J Autoimmun; 2008 Sep; 31(2):175-9. PubMed ID: 18707846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating tumour necrosis factor-alpha bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response.
    Marotte H; Maslinski W; Miossec P
    Arthritis Res Ther; 2005; 7(1):R149-55. PubMed ID: 15642135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy.
    Chen DY; Chen YM; Chen HH; Hsieh CW; Lin CC; Lan JL
    Arthritis Res Ther; 2011 Jul; 13(4):R126. PubMed ID: 21801431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased tumor necrosis factor-alpha mRNA expression in whole blood from patients with rheumatoid arthritis: reduction after infliximab treatment does not predict response.
    Pachot A; Arnaud B; Marrote H; Cazalis MA; Diasparra J; Gouraud A; Mougin B; Miossec P
    J Rheumatol; 2007 Nov; 34(11):2158-61. PubMed ID: 17896807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of decoy receptor- and antibody-mediated tumour necrosis factor blockage on FoxP3 expression in responsive arthritis patients.
    Ryder LR; Ryder LP; Bartels EM; Woetmann A; Madsen HO; Ødum N; Danneskiold-Samsøe B; Ribel-Madsen S; Bliddal H
    APMIS; 2013 Apr; 121(4):337-47. PubMed ID: 23031059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of interleukin-8 in dialysis-related arthritis.
    Takayama F; Miyazaki T; Aoyama I; Tsukushi S; Sato M; Yamazaki C; Shimokata K; Niwa T
    Kidney Int; 1998 Apr; 53(4):1007-13. PubMed ID: 9551411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BDNF in RA: downregulated in plasma following anti-TNF treatment but no correlation with inflammatory parameters.
    Grimsholm O; Rantapää-Dahlqvist S; Dalén T; Forsgren S
    Clin Rheumatol; 2008 Oct; 27(10):1289-97. PubMed ID: 18484150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.